---
figid: PMC3645661__ijms-14-06690f1
figlink: /pmc/articles/PMC3645661/figure/f1-ijms-14-06690/
number: Figure 1
caption: 'An overview of signaling by the EGF family (with EGF and EGFR/ErbB1 as example)
  from cell surface down to the nucleus (without taking into account endocytic trafficking
  and recycling of the receptor). In the absence of ligand (left panel), LRIG1, a
  negative regulator (red line), binds to the EGFR and both are degraded by less well-studied
  mechanisms. In addition, unliganded EGFR can also be sent into E3 ubiquitin ligase-Socs4/5-assisted
  ubiquitylation and degradation. In the presence of ligand (middle and right panel),
  still two outcomes are possible. In the first, positive signaling (green arrows)
  is initiated via Grb2, resulting in activation of downstream kinase cascades Raf–Mek–Erk
  (Erk or Mapk) and PI3K–PDK–Akt, which is a prototypic survival pathway that is constitutively
  activated in many types of cancer. The latter cascades are also subject to negative
  regulation exerted by dual-specificity phosphatases (Dusp) and the tumor-suppressor
  PTEN, respectively. In the nucleus, Erk teams up with an activated TF to induce
  transcription of cell proliferation genes. In the second, degradation versus recycling
  is still an option, one initiated via Grb2 and one—also in a ligand-dependent manner—where
  LRIG1-Cbl (Cbl is an E3 ubiquitin–protein ligase) and probably direct EGFR–Cbl interaction
  ensure full ubiquitylation and hence degradation of the EGFRs. Finally, also RALT,
  a pan-ErbB inhibitor, acts at this level: it inhibits EGFR allosteric kinase activation.
  Grey boxes highlight the aptamers discussed in the main text, together with the
  references.'
pmcid: PMC3645661
papertitle: Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin
  and TGFβ–Smad Family Signaling.
reftext: Andrea Conidi, et al. Int J Mol Sci. 2013 Apr;14(4):6690-6719.
pmc_ranked_result_index: '90921'
pathway_score: 0.9638228
filename: ijms-14-06690f1.jpg
figtitle: An overview of signaling by the EGF family (with EGF and EGFR/ErbB1 as example)
  from cell surface down to the nucleus (without taking into account endocytic trafficking
  and recycling of the receptor)
year: '2013'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3645661__ijms-14-06690f1.html
  '@type': Dataset
  description: 'An overview of signaling by the EGF family (with EGF and EGFR/ErbB1
    as example) from cell surface down to the nucleus (without taking into account
    endocytic trafficking and recycling of the receptor). In the absence of ligand
    (left panel), LRIG1, a negative regulator (red line), binds to the EGFR and both
    are degraded by less well-studied mechanisms. In addition, unliganded EGFR can
    also be sent into E3 ubiquitin ligase-Socs4/5-assisted ubiquitylation and degradation.
    In the presence of ligand (middle and right panel), still two outcomes are possible.
    In the first, positive signaling (green arrows) is initiated via Grb2, resulting
    in activation of downstream kinase cascades Raf–Mek–Erk (Erk or Mapk) and PI3K–PDK–Akt,
    which is a prototypic survival pathway that is constitutively activated in many
    types of cancer. The latter cascades are also subject to negative regulation exerted
    by dual-specificity phosphatases (Dusp) and the tumor-suppressor PTEN, respectively.
    In the nucleus, Erk teams up with an activated TF to induce transcription of cell
    proliferation genes. In the second, degradation versus recycling is still an option,
    one initiated via Grb2 and one—also in a ligand-dependent manner—where LRIG1-Cbl
    (Cbl is an E3 ubiquitin–protein ligase) and probably direct EGFR–Cbl interaction
    ensure full ubiquitylation and hence degradation of the EGFRs. Finally, also RALT,
    a pan-ErbB inhibitor, acts at this level: it inhibits EGFR allosteric kinase activation.
    Grey boxes highlight the aptamers discussed in the main text, together with the
    references.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOS1
  - SHC3
  - SHC1
  - SHC4
  - LRIG1
  - SOCS4
  - PDK1
  - PDK2
  - MAP2K1
  - PDK4
  - MAP2K2
  - SHC2
  - PIK3CG
  - PIK3R3
  - RAF1
  - MTOR
  - PLCD1
  - PDK3
  - TF
  - ARAF
  - PIK3CD
  - PLCD3
  - PLCB1
  - PLCE1
  - PLCB3
  - PLCB4
  - DUSP2
  - PLCG1
  - PLCG2
  - ERRFI1
  - PIK3R6
  - NRAS
  - HRAS
  - PLCD4
  - GRB2
  - AKT3
  - AKT1
  - CBL
  - PLCB2
  - DUSP5
  - DUSP6
  - DUSP3
  - PLCZ1
  - PTEN
  - SOS2
  - PIK3CB
  - MAPK3
  - PIK3CA
  - PRKCQ
  - PRKD3
  - PRKCA
  - DUSP4
  - PTPRJ
  - KRAS
  - MAPK1
  - PIK3R4
  - EGF
  - PRKCH
  - EGFR
  - PIK3R5
  - AKT2
  - PRKCB
  - PRKCG
  - DUSP1
  - PRKCI
  - PRKCE
  - PRKCZ
  - BRAF
  - PRKCD
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: LRIG1
  symbol: LRIG1
  source: hgnc_symbol
  hgnc_symbol: LRIG1
  entrez: '26018'
- word: Socs4/S
  symbol: SOCS4
  source: hgnc_symbol
  hgnc_symbol: SOCS4
  entrez: '122809'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: Dusp
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: RALT
  symbol: RALT
  source: hgnc_alias_symbol
  hgnc_symbol: ERRFI1
  entrez: '54206'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Cbl
  symbol: CBL
  source: hgnc_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: Dusp
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: Dusp
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: Dusp
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Dusp
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: Dep1
  symbol: DEP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPRJ
  entrez: '5795'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Dusp
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: (ErbB1)
  symbol: ERBB1
  source: hgnc_alias_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
